Skip to Content
Skip to Menu
Skip to Footer

Our mission

To curate knowledge to advance the world's most promising biomedical innovations

image of the biorelate staff with banner of biorelate logo behind them
Our story

The most advanced data curation in biopharma

Biorelate was founded in 2014 from cutting-edge scientific research into how biomedical curation can utilise existing dark knowledge to accelerate future drug discovery. Staying true to our roots, we have always believed that a better understanding of today’s science can bring forward the next generation of life-saving therapeutics being developed by world-leading researchers.

As the incredible progress of scientific researchers continues to compound the huge volume of growing and evolving biomedical data, Biorelate’s mission has never been so important. Through our platform, Galactic AI™, we use artificial intelligence-led curation to provide and enable the insights that matter to scientists and organisations developing the innovations of the future.

Our Values

At Biorelate, our values define our behaviour in everything we do as a company.


We embrace change as we know this shapes our future. We are insightful, always exploring new possibilities and actively seeking new ideas.


We take ownership in everything we do, we take pride in our output and delivery and celebrate success.


We are open-minded, flexible and responsive in our approach, always willing to adapt to deliver excellence.


We understand each other's worth and abilities and continually support and challenge one another to achieve greatness. We are one team, working toward the same goal.


We show integrity and are transparent and respectful of everyone. We communicate openly and honestly to solve a problem.

Our board and advisors

Board and advisers
Daniel Jamieson

CEO & Founder, Biorelate

Board and advisers
Deborah Kobewka

Chair, Biorelate

Board and advisers
Gareth King

Life Science Partner, Catapult Ventures Group

Board and advisers
Gavin Bell

Senior Investment Manager, Maven Capital Partners

Board and advisers
Gavin Chadwick

Portfolio Director, YFM Equity Partners


Meet the leadership team.

Over 80 years of experience

The leadership team
Daniel Jamieson
CEO & Founder
The leadership team
Katie Brownridge
Vice President of Operations
The leadership team
Darren Hoyland
Vice President of Technology
The leadership team
Tim Collin
Interim Vice President of Sales and Marketing
The leadership team
Peter Revill
Head of Product
The leadership team
Bronwyn Murray
Vice President of Finance

Our History


Company founded. Manchester University PhD spinout after success working with Pfizer.


Completed >10 contracts for customers that include biotechs & pharmaceutical companies.


Raised investment with Catapult Ventures, Maven & angel investors


Galactic AI™ official product launch, following early adopter success.


Raised further investment from YFM, Maven, Triplepoint and other investors.

Would you like to join our mission?

We’re always on the lookout for talented software developers, bioinformaticians and industry professionals in full-time and internship positions.

Explore Galactic AI™

Request a demo or contact us to see Galactic AI™ in action, and discover how it provides data scientists and computational biologists with unmatched cause-and-effect evidence in biopharma.